Catalyst Wire Dossier Catalyst Wire Dossier

ADI-PEG 20 (Pegylated arginine deiminase)

pegylated arginine deiminase
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADI-PEG 20 (Pegylated arginine deiminase), covering 2013-05-01 to 2013-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Pegylated Arginine Deiminase in Treating Patients With Metastatic Melanoma That Cannot Be Removed by Surgery [Phase 2]

See pricing